feed,title,long_url,short_url
Investors,"The 'Key Negative' That Took Out Medpace's Sales, Profit Beat",https://www.investors.com/news/technology/medpace-stock-medpace-earnings-q4-2025/,
Investors,Oracle Stock Looks To Extend Rally With OpenAI In Focus,https://www.investors.com/news/technology/oracle-stock-openai-orcl-news/,
Investors,AstraZeneca Leans On Its Cancer Division For A Fourth-Quarter Beat,https://www.investors.com/news/technology/astrazeneca-stock-astrazeneca-earnings-q4-2025/,
Investors,Evommune Nearly Doubles â€” Has Dupixent Met Its Match In Eczema?,https://www.investors.com/news/technology/ipo-stock-evommune-eczema-treatment-dupixent/,
Investors,"Robinhood Earnings To Test Crypto Weakness, Prediction Markets Strength",https://www.investors.com/news/robinhood-earnings-q4-2025-hood-stock-prediction-markets-crypto/,
